731 filings
Page 33 of 37
8-K
2k0bxi zy5sfvo459p0
19 Jun 07
Other Events
12:00am
424B3
t9vbikvr 9gq0y99
11 Jun 07
Prospectus supplement
12:00am
8-K
xqvgtb30
8 Jun 07
Acorda Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock
12:00am
424B4
c0ttkmmrrb5uvio
8 Jun 07
Prospectus supplement with pricing info
12:00am
EFFECT
oiybmngp9a
7 Jun 07
Notice of effectiveness
12:00am
8-K
o5lc6
6 Jun 07
Acorda Therapeutics Begins Second Phase 3 Clinical Trial of
12:00am
S-3/A
8cbag
4 Jun 07
Shelf registration (amended)
12:00am
8-K
wjwai74
4 Jun 07
Acorda Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
12:00am
S-3
xxmy0mgcrn pv
30 May 07
Shelf registration
12:00am
8-K
w7gmmnu7
22 May 07
Acorda Therapeutics and FDA Reach Agreement on Special Protocol Assessment for Second Phase 3 Study of Fampridine-SR in Multiple Sclerosis
12:00am
8-K
nsw00no l4ccxw
10 May 07
Acorda Therapeutics Reports First Quarter 2007 Financial Results
12:00am
DEF 14A
e4y7ot8 bs2o
8 May 07
Definitive proxy
12:00am
8-K
qff0fpamqt gp
2 May 07
Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting
12:00am
EFFECT
5luool8ananr
9 Apr 07
Notice of effectiveness
12:00am
POS AM
ahr7odsjl
29 Mar 07
Prospectus update (post-effective amendment)
12:00am
424B3
vld14juqs5hny
26 Mar 07
Prospectus supplement
12:00am
8-K
llbgyg c6l
21 Mar 07
Amendments to Articles of Incorporation or Bylaws
12:00am